9 Feb 2017

Lupin US approval

Lupin’s stream of ANDA approvals in the US continues. The company has received approval to market its morphine sulfate extended release tablets for pain management, Paroxetan extended release tablets, a generic version of Paxil anti-depressant and a generic version of the Ortho Cyclon contraceptive pill. Nestle’s MAGGI instant noodles have now recovered 60% market share since the additive scandal. Bajaj Auto is planning to re-enter the Indonesian motorcycle market with its European brand KTM. Kotak Mahindra Bank has sold a 2.1% interest in South Indian Bank for a consideration in the region of $10mil. The bank has been instructed by the RBI to cut its promoter’s interest to 30% by June 2017 and to 20% by June 2018.

No comments:

Post a Comment